WILLIAMS AND JENSEN, PLLC

Lobbying for RAYNER · Manufacturer of ophthalmic medical products.

Filing 4th Quarter - Report

4th Quarter (Oct 1 - Dec 31) 2025 · House · Senate · $60,000.00 income · posted Jan 20, 2026

Lobbying activity 1

Medicare/Medicaid

Medicare coverage issue for non-opioid product. Reauthorization of NOPAIN Act.

Source: federal Lobbying Disclosure Act filing. Bills are parsed from the activity descriptions.

Report a problem